Qualitative dynamics of a vaccination model for HSV-2

被引:20
作者
Podder, Chandra N. [1 ]
Gumel, Abba B. [1 ]
机构
[1] Univ Manitoba, Dept Math, Winnipeg, MB R3T 2N2, Canada
关键词
herpes simplex virus type 2; vaccine; equilibria; reproduction number; stability; backward bifurcation; SIMPLEX-VIRUS TYPE-2; BACKWARD BIFURCATIONS; DRUG-RESISTANCE; PUBLIC-HEALTH; HERPES; TRANSMISSION; INFECTION; DISEASE; SEROPREVALENCE; EMERGENCE;
D O I
10.1093/imamat/hxp030
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
A new mathematical model for the transmission dynamics of herpes simplex virus type 2 (HSV-2), which takes into account disease transmission by infected individuals in the quiescent state and an imperfect HSV-2 vaccine, is designed and qualitatively analysed. In the absence of vaccination, it is shown that the model has a globally asymptotically stable (GAS) disease-free equilibrium (DFE) point whenever an epidemiological threshold, known as the 'basic reproduction number', is less than unity. Further, this model has a unique endemic equilibrium whenever the reproduction number exceeds unity. Using a non-linear Lyapunov function, it is shown that the unique endemic equilibrium is GAS (for a special case) when the associated reproduction threshold is greater than unity. On the other hand, the model with vaccination undergoes a vaccine-induced backward bifurcation, where the stable DFE coexists with a stable endemic equilibrium when the reproduction threshold is less than unity. Threshold analysis of the vaccination model reveals that the use of an imperfect HSV-2 vaccine could have positive or negative population-level impact (in reducing disease burden). Simulations of the vaccination model show that an HSV-2 vaccine could lead to effective disease control or elimination if the vaccine efficacy and the fraction of susceptible individuals vaccinated at steady state are high enough (at least 80% each).
引用
收藏
页码:75 / 107
页数:33
相关论文
共 41 条
[1]  
ANDERSON RM, 1990, INFECT DIS HUMANS DY
[2]  
[Anonymous], 2012, Applications of centre manifold theory
[3]   Therapeutic options for herpes simplex infections [J].
Eugene Au ;
Stephen L. Sacks .
Current Infectious Disease Reports, 2003, 5 (1) :22-27
[4]   Herpes simplex virus type 2 vaccines: New ground for optimism? [J].
Aurelian, L .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2004, 11 (03) :437-445
[5]   HIV infection among youth in a South African mining town is associated with herpes simplex virus-2 seropositivity and sexual behaviour [J].
Auvert, B ;
Ballard, R ;
Campbell, C ;
Caraël, M ;
Carton, M ;
Fehler, G ;
Gouws, E ;
MacPhail, C ;
Taljaard, D ;
Van Dam, J ;
Williams, B .
AIDS, 2001, 15 (07) :885-898
[6]  
Blower S, 2002, QUANTIATIVE EVALUATION OF HIV PREVENTION PROGRAMS, P260
[7]   Predicting and preventing the emergence of antiviral drug resistance in HSV-2 [J].
Blower, SM ;
Porco, TC ;
Darby, G .
NATURE MEDICINE, 1998, 4 (06) :673-678
[8]   Backward bifurcations in simple vaccination models [J].
Brauer, F .
JOURNAL OF MATHEMATICAL ANALYSIS AND APPLICATIONS, 2004, 298 (02) :418-431
[9]   Dynamical models of tuberculosis and their applications [J].
Castillo-Chavez, C ;
Song, BJ .
MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2004, 1 (02) :361-404
[10]   Genital herpes and public health - Addressing a global problem [J].
Corey, L ;
Handsfield, HH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (06) :791-794